Glutamine treatment attenuates hyperglycemia-induced mitochondrial stress and apoptosis in umbilical vein endothelial cells

Clinics

Volumn 70, Issue 8, 2015, Pages 569-576

  Safi, Sher Zaman ^a   Batumalaie, Kalaivani ^a   Mansor, Marzida ^a   Chinna, Karuthan ^a   Mohan, Syam ^a   Karimian, Hamed ^a   Qvist, Rajes ^a   Ashraf, Muhammad Aqeel ^a   Siok Yan, Garcie Ong ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Apoptosis; Cytokine; Glutamine; Hyperglycemia; Sepsis

Indexed keywords

ANTIDIABETIC AGENT; CYTOCHROME C; CYTOKINE; DRUG COMBINATION; GLUTAMINE; INSULIN;

APOPTOSIS; CELL CULTURE; CELL MEMBRANE PERMEABILITY; DRUG COMBINATION; DRUG EFFECTS; EVALUATION STUDY; HUMAN; HYPERGLYCEMIA; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; UMBILICAL VEIN ENDOTHELIAL CELL;

APOPTOSIS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CYTOCHROMES C; CYTOKINES; DRUG COMBINATIONS; GLUTAMINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84938788540     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2015(08)07     Document Type: Article

References (44)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86, http://dx.doi.org/10.1056/NEJM199309303291401.
2. Safi SZ, Qvist R, Kumar S, Batumalaie K, Ismail IS. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int. 2014;2014:801-269, http://dx.doi.org/10.1155/2014/801269.
3. Safi SZ, Qvist R, Yan GO, Ismail IS. Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of b1, b2 and b3-adrenergic receptors in retinal endothelial cells. BMC Med Genomics. 2014;7:29, http://dx.doi.org/10.1186/1755-8794-7-29.
4. Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J. 1992;6(11):2905-14.
5. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-67, http://dx.doi.org/10.1056/NEJMoa011300.
6. Oritz A, Ziyadeh FN, Neilson EG. Expression of apoptosis regulatory gene in renal proximal epithelial cells exposed to high ambient glucose and diabetic kidneys. J Investig Med. 1997;45(2):50-6.
7. Safi SZ, Shah H, Siok Yan GO, Qvist R. Insulin resistance provides the connection between hepatitis C virus and diabetes. Hepat Mon. 2014;15 (1):e23941, http://dx.doi.org/10.5812/hepatmon.
8. Li W, Yanoff M, Liu X, Ye X. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Chin Med J (Engl). 1997;110(9):659-63.
9. Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci. 2000;41(12):3972-8.
10. Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A et al. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin IIdependent. Lab Invest. 2000;80(4):513-27, http://dx.doi.org/10.1038/labinvest.3780057.
11. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A et al. Myocardial cell death in human diabetes. Circ Res. 2000;87(12):1123-32, http://dx.doi.org/10.1161/01.RES.87.12.1123.
12. Marik PE, Varon J. Sepsis: State of the art. Dis Mon. 2001; 47:463-532, http://dx.doi.org/10.1067/mda.2001.119745.
13. Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis. 2007;27(4):339-50, http://dx.doi.org/10.1055/s-2007-991511.
14. Barnes PJ, Karin M. Nuclear Factor–Kb-A pivotal transcription Factor in chronic inflammatory diseases. N Engl J Med. 1997;336(15):1066-71, http://dx.doi.org/10.1056/NEJM199704103361506.
15. Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res. 2003;60(1):49-57, http://dx.doi.org/10.1016/S0008-6363(03)00397-3.
16. Frey EA, Finlay BB. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway. Microb Pathog. 1998;24(2):101-9, http://dx.doi.org/10.1006/mpat.1997.0178.
17. Robaye B, Mosselmans R, FiersW, Dumont JE, Galand P. Tumour necrosis factor induces apoptosis (Programmed cell death) in normal endothelial cells in vitro. Am J. Pathol. 1991; 138(2):447-53.
18. Heike B and Klaus SO. Cell death in sepsis: a matter of how, when, and where? Critical Care. 2009;13(4):173, http://dx.doi.org/10.1186/cc7966.
19. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997;112(1):235-43, http://dx.doi.org/10.1378/chest.112.1.235.
20. Garrabou G, Morén C, López S, Tobías E, Cardellach F, Miró O, et al. The Effects of Sepsis on Mitochondria. J Infect Dis. 2012;205(3):392-400, http://dx.doi.org/10.1093/infdis/jir764.
21. Ruchko M, Gorodnya O, LeDoux SP, Alexeyev MF, Al-Mehdi AB, Gillespie MN. Mitochondrial DNA damage triggers mitochondrial dysfunction and apoptosis in oxidant-challenged lung endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;288(3):L530-5, http://dx.doi.org/10.1152/ajplung.00255.2004.
22. Karamysheva AF. Mechanisms of angiogenesis. Biochemistry (Mosc). 2008;73(7):751-62, http://dx.doi.org/10.1134/S0006297908070031.
23. Kumar S, Safi SZ, Qvist R and Ismail ISB. Effect of agonists of adenosine receptors on inflammatory markers in human Muller cells. Current Science. 2014;106(4):582-6.
24. Cheah SC, Appleton DR, Lee ST, Lam ML, Hadi AH, Mustafa MR. Panduratin A inhibits the growth of A549 cells through induction of apoptosis and inhibition of NF-kappaB translocation. Molecules. 2011;16 (3):2583-98, http://dx.doi.org/10.3390/molecules16032583.
25. Wenhua G, Yongmei P, Kathy QL. Temporal relationship between cytochrome c release and mitochondrial swelling during UV-induced apoptosis in living HeLa cells. J Cell Sci. 2001;114(Pt 15):2855-62.
26. Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood. 2001;98(5):1542-8, http://dx.doi.org/10.1182/blood.V98.5.1542.
27. Nageswara R, Madamanchi, Marschall, S. Runge. Mitochondrial Dysfunction in Atherosclerosis. Circ Res. 2007;100(4):460-73, http://dx.doi.org/10.1161/01.RES.0000258450.44413.96.
28. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, et al. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J. 2002;16(13):1738-48, http://dx.doi.org/10.1096/fj.01-1027com.
29. Magdalena LC, Tak YA. Glutathione and apoptosis. Free Radic Res. 2008;42(8):689–706, http://dx.doi.org/10.1080/10715760802317663.
30. Marc WF, Catherine BC, Manisha P. Role of mitochondria in toxic oxidative stress. Mol Interv. 2005;5(2):94-111, http://dx.doi.org/10.1124/mi.5.2.7.
31. Hsin CL, Yau HW. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol. 2005;37(4):822-34, http://dx.doi.org/10.1016/j.biocel.2004.09.010.
32. Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res. 2003;60 (1):49-57, http://dx.doi.org/10.1016/S0008-6363(03)00397-3.
33. Yu Wk, Li Wq, Li N. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counter regulatory hormone concentrations. World J Gastroenterol. 2003;9(8):1824-7
34. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007;11(2):R49, http://dx.doi.org/10.1186/cc5783
35. Blackwell TS, Christman JW. Sepsis and cytokines: Current Status. Br J Anaesth. 1996;77(1):110-7, http://dx.doi.org/10.1093/bja/77.1.110.
36. Donnelly SC, Strieter RM, Reid PT. The association between mortality rates and decreased concentrations of interleukin-10, and interleukin-1 receptor antagonist in the lung fields of patients with adult respiratory distress symptom. Ann Intern Med. 1996;125(3):191-6, http://dx.doi.org/10.7326/0003-4819-125-3-199608010-00005.
37. Damico RL, Chesley A, Johnston L, Bind EP, Amaro E, Nijmeh J, et al. Macrophage migration inhibitory factor governs endothelial cell sensitivity to LPS induced Apoptosis. Am J Respir Cell Mol Biol. 2008;39(1): 77-85, http://dx.doi.org/10.1165/rcmb.2007-0248OC.
38. Dinarello CA. Interleukin 1, interleukin-1 receptors, and interleukin-1 receptor antagonist. Int Rev Immunol. 1998;16(5-6):457-99, http://dx.doi.org/10.3109/08830189809043005.
39. Yeh SL, Lai YN, Shang HF, Lin MT, Chiu WC, Chen WJ. Effects of glutamine supplementation on splenocyte cytokine m RNA in rats with septic peritonitis. World J Gastroenterol. 2005;11(12):1742-6, http://dx.doi.org/10.3748/wjg.v11.i12.1742.
40. Kelly D, and Wischmeyer PE. Role of L-glutamine in critical illness. New insights. Curr Opin Clin Nutr Metab Care. 2003;6(2):217-22, http://dx.doi.org/10.1097/00075197-200303000-00011.
41. Liang M, Wang X, Yuan Y, Zhou Q, Tong C, Jiang W. Different effect of Glutamine on macrophage tumour nnnnecrosis factor –alpha release and heat shock protein 72 expression in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai). 2009;41(2):171-7.
42. Xumin W, Ying X, Menfan L. Glutamine treatment decreases plasma lymph cytotoxicity during sepsis in rats. Acta Biochim Biophys Sin (Shanghai). 2012;44(9):774-82.
43. Liang M, Wang X, Yuan Y, Zhou Q, Tong C, and Jiang W. Different effect of glutamine on macrophage tumour necrosis factor alpha release and heat shock protein 72 expression in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai). 2009;41(2):171-7.
44. Hou YCI, Pai M, Hchiu WC, Hu YM, Yeh SL. Effects of dietary glutamine supplementation on lung injury induced by lipopolysaccharide administration. Am J Physiol Lung Cell Mol Physiol. 2009;296(3):L288-95, http://dx.doi.org/10.1152/ajplung.90479.2008.